Search results for "Post-hoc analysis"

showing 10 items of 59 documents

Inclusive Teachers’ Concern and Rejection Toward Their Students

2008

This article reports two related studies. In the first study, concern and rejection ratings of 14 inclusive teachers toward 26 students with disabilities were correlated with teacher—student interactions. Partial correlations, controlling for severity of disability, indicated that instructional-academic interactions corresponded significantly with teachers’ concern ratings and noninstructional-behavioral interactions corresponded significantly with teachers’ rejection ratings. In the second study, the authors compared teachers’ concern and rejection ratings of students with learning disabilities ( n = 77), cognitive disabilities ( n = 44), attention-deficit disorder ( n = 20), behavioral d…

Cognitive disabilitieseducationLearning disabilityPost-hoc analysisPublic Health Environmental and Occupational HealthmedicineRejection (Psychology)medicine.symptomMainstreamingPsychologyInclusion (education)EducationClinical psychologyRemedial and Special Education
researchProduct

Comparative efficacy of aloe vera mouthwash and chlorhexidine on periodontal health: A randomized controlled trial

2016

Background: With introduction of many herbal medicines, dentistry has recently evidenced shift of approach for treating many inflammatory oral diseases by using such modalities. Aloe vera is one such product exhibiting multiple benefits and has gained considerable importance in clinical research recently. Aims: To compare the efficacy of Aloevera and Chlorhexidine mouthwash on Periodontal Health. Material and Methods: Thirty days randomized controlled trial was conducted among 390 dental students. The students were randomized into two intervention groups namely Aloe Vera (AV) chlorhexidine group (CHX) and one control (placebo) group. Plaque index and gingival index was recorded for each par…

DentistryOdontologíaDental plaquePlacebo030226 pharmacology & pharmacyAloe veralaw.invention03 medical and health sciencesGingivitis0302 clinical medicineRandomized controlled triallawPost-hoc analysismedicineGeneral Dentistrybiologybusiness.industryResearchChlorhexidineSignificant difference030206 dentistrymedicine.diseasebiology.organism_classificationCiencias de la saludCommunity and Preventive DentistryUNESCO::CIENCIAS MÃ DICAS:CIENCIAS MÃ DICAS [UNESCO]medicine.symptombusinessmedicine.drugJournal of Clinical and Experimental Dentistry
researchProduct

Consenso Delphi sobre el diagnóstico y manejo de la dislipidemia en pacientes con enfermedad renal crónica: análisis post-hoc del estudio DIANA

2016

Resumen Antecedentes y objetivos: Este estudio post hoc analizó la percepción de la importancia de la enfermedad renal crónica (ERC) en el cribado de la dislipidemia y en la elección del tratamiento con estatinas entre médicos de Atención Primaria (MAP) y otras especialidades mediante cuestionario Delphi. Métodos: El cuestionario incluyó 4 bloques de preguntas alrededor del paciente dislipémico con alteración del metabolismo hidrocarbonado. Aquí se presentan los resultados relacionados con la consideración de la ERC en el cribado y la elección de la estatina. Resultados: De los 497 expertos incluidos, el 58% eran MAP y el 42%, especialistas (35, el 7%, nefrólogos). Hubo consenso en realizar…

DyslipidaemiaPulmons -- Malalties obstructivesRiesgo cardiovascularDelphi Technique030204 cardiovascular system & hematologylcsh:RC870-923urologic and male genital diseases0302 clinical medicineRisk FactorsSurveys and QuestionnairesChronic kidney diseaseMedicine030212 general & internal medicinecomputer.programming_languagemedicine.diagnostic_testLipidsfemale genital diseases and pregnancy complicationsCardiovascular DiseasesNephrologylipids (amino acids peptides and proteins)medicine.symptomEstatinasGlomerular Filtration Ratemedicine.medical_specialtyConsensusStatinRonyons -- Malaltiesmedicine.drug_classRenal function03 medical and health sciencesInternal medicineDislipidemiaPost-hoc analysisAlbuminuriaHumansRenal Insufficiency ChronicIntensive care medicineEnfermedad renal crónicaDyslipidemiasbusiness.industryStatinsnutritional and metabolic diseasesGuidelineCardiovascular risklcsh:Diseases of the genitourinary system. Urologymedicine.diseaseEndocrinologyAlbuminuriabusinessLipid profilecomputerDelphiKidney diseaseNefrología (English Edition)
researchProduct

Soluble ST2 and Diuretic Efficiency in Acute Heart Failure and Concomitant Renal Dysfunction

2021

Abstract Background Identifying patients at risk of poor diuretic response in acute heart failure (AHF) is critical to make prompt adjustments in therapy. The objective of this study was to investigate whether the circulating levels of soluble ST2 predict the cumulative diuretic efficiency (DE) at 24 and 72 hours in patients with AHF and concomitant renal dysfunction. Methods and Results This is a post hoc analysis of the IMPROVE-HF trial, in which we enrolled 160 patients with AHF and renal dysfunction (estimated glomerular filtrate rate of Conclusions In patients with AHF and renal dysfunction at presentation, circulating levels of sST2 were independently and negatively associated with a …

Heart Failuremedicine.medical_specialtybusiness.industrymedicine.medical_treatment030204 cardiovascular system & hematologymedicine.disease03 medical and health sciences0302 clinical medicineFurosemideNegatively associatedInternal medicineConcomitantHeart failureAcute DiseasePost-hoc analysisCardiologyHumansMedicineKidney DiseasesIn patient030212 general & internal medicineDiureticDiureticsCardiology and Cardiovascular MedicinebusinessJournal of Cardiac Failure
researchProduct

PO-279 Bidirectional Associations Between Physical Activity and Adiposity From Childhood to Early Adulthood

2018

Objective Inverse association between physical activity and adiposity in children and adolescents have been documented in numerous studies. However, few studies have examined the direction of causation between these two variables. We aimed to examine the prospective bidirectional associations between physical activity and adiposity from childhood to early adulthood.
 Methods A total of 396 girls (mean age, 11.2 years at baseline) participated in a longitudinal study with 1, 2, 4, and 7 year follow-ups. Body height and weight were measured, body composition was assessed by DXA and BMI and fat mass index (FMI) were calculated. Leisure-time physical activity (LTPA) and physical inactivity…

Longitudinal studyLeast significant differencebusiness.industryPost-hoc analysisEarly adulthoodPhysical activityMedicineAnalysis of variancebusinessmedicine.diseaseObesityPhysical activity levelDemographyExercise Biochemistry Review
researchProduct

On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites

2021

Background & Aims: The ANSWER study reported that long-term albumin administration in patients with cirrhosis and uncomplicated ascites improves survival. During treatment, serum albumin increased within a month and remained stable thereafter. In this post hoc analysis, we aimed to determine whether on-treatment serum albumin levels could guide therapy. Methods: Logistic regression was used to assess the association between baseline serum albumin and mortality, as well as to determine on-treatment factors associated with mortality and to predict the achievement of a given on-treatment serum albumin level. Survival was assessed by Kaplan-Meier estimates and second-order polynomial regres…

Male0301 basic medicineCirrhosisascites; complications; liver cirrhosis; serum albumin; survivalSerum albuminSurvival.Logistic regressionGastroenterologyBiomarkers PharmacologicalAscites; Cirrhosis; Complications; Serum albumin; Survivalascites0302 clinical medicineAscitesMedicinebiologyMiddle AgedIntention to Treat AnalysisTreatment OutcomeCirrhosisAsciteFemale030211 gastroenterology & hepatologyDrug Monitoringmedicine.symptommedicine.medical_specialtycomplicationsSettore MED/12 - GASTROENTEROLOGIAliver cirrhosisSerum albuminSerum Albumin Humansurvival03 medical and health sciencesSerum albumin levelPredictive Value of TestsInternal medicinePost-hoc analysisHumansIn patientBiological ProductsCirrhosiHepatologybusiness.industryAlbuminmedicine.diseaseLong-Term CareSurvival Analysis030104 developmental biologybiology.proteinbusinessComplication
researchProduct

The "gender factor" in wearing-off among patients with parkinson's disease: A post hoc analysis of DEEP study

2014

Background. The early detection of wearing-off in Parkinson disease (DEEP) observational study demonstrated that women with Parkinson’s disease (PD) carry an increased risk (80.1%) for wearing-off (WO). This post hoc analysis of DEEP study evaluates gender differences on WO and associated phenomena.Methods. Patients on dopaminergic treatment for ≥1 year were included in this multicenter observational cross-sectional study. In a single visit, WO was diagnosed based on neurologist assessment as well as the use of the 19-item wearing-off questionnaire (WOQ-19); WO was defined for scores ≥2. Post hoc analyses were conducted to investigate gender difference for demographic and clinical features …

MaleGenetics and Molecular Biology (all)medicine.medical_specialtyLevodopaParkinson's diseaseArticle SubjectCross-sectional studylcsh:MedicineDiseaseAged; Akathisia Drug-Induced; Antiparkinson Agents; Cross-Sectional Studies; Female; Gait; Humans; Levodopa; Male; Parkinson Disease; Risk Factors; Severity of Illness Index; Sex Factors; Medicine (all); Biochemistry Genetics and Molecular Biology (all); 2300lcsh:TechnologySeverity of Illness IndexBiochemistryGeneral Biochemistry Genetics and Molecular BiologyAntiparkinson AgentsLevodopaSex FactorsRisk FactorsInternal medicinePost-hoc analysisSeverity of illnessBIO/14 FarmacologiamedicineHumansProspective cohort studylcsh:ScienceGaitGeneral Environmental ScienceAgedAged; Akathisia Drug-Induced; Antiparkinson Agents; Cross-Sectional Studies; Female; Gait; Humans; Levodopa; Male; Parkinson Disease; Risk Factors; Severity of Illness Index; Sex Factors; Biochemistry Genetics and Molecular Biology (all); 2300; Medicine (all)2300business.industrylcsh:TMedicine (all)lcsh:RParkinson DiseaseGeneral Medicinemedicine.diseaseAkathisiaCross-Sectional StudiesDrug-InducedPhysical therapyObservational studylcsh:QFemalebusinessAkathisia Drug-InducedResearch Articlemedicine.drug
researchProduct

Inhibitory avoidance in CD1 mice: sex matters, as does the supplier.

2013

The purpose of the present work was to study possible differences in the learning of inhibitory avoidance (also called passive avoidance) in male and female CD1 mice acquired from three different suppliers, for which a one-trial step-through version of the paradigm was employed. Ninety-six mice from Charles River (France), Janvier (France) and Harlan (The Netherlands) laboratories were divided by sex and assigned to group C, J or H, respectively (n=16). The animals were tested in the training phase (foot-shock: 0.3mA, 5s) and again for avoidance (no foot-shock delivered) one week later. Inhibitory avoidance learning (test latencies significantly higher than training latencies) was observed …

MaleSex CharacteristicsPhysiologyGeneral MedicineInhibitory postsynaptic potentialDevelopmental psychologyBehavioral NeuroscienceMiceSex FactorsAvoidance learningSex factorsPost-hoc analysisAvoidance LearningTraining phaseAnimalsAnimal Science and ZoologyFemalePassive avoidanceAnimal HusbandryPsychologySex characteristicsBehavioural processes
researchProduct

Is high-sensitivity troponin, alone or in combination with copeptin, sensitive enough for ruling out NSTEMI in very early presenters at admission? A …

2019

Objectives: Copeptin and high-sensitivity cardiac troponin (HS-cTn) assays improve the early detection of non-ST-segment elevation myocardial infarction (NSTEMI). Their sensitivities may, however, be reduced in very early presenters.Setting: We performed a post hoc analysis of three prospective studies that included patients who presented to the emergency department for chest pain onset (CPO) of less than 6 hours.Participants: 449 patients were included, in whom 12% had NSTEMI. CPO occurred 4 hours in 146 patients. The prevalence of NSTEMI was similar in all groups (9%, 13% and 12%, respectively, p=0.281).Measures: Diagnostic performances of HS-cTn and copeptin at presentation were examined…

MaleTime Factors030204 cardiovascular system & hematologyChest pain0302 clinical medicinehigh sensitive cardiac troponinTroponin IMedicine1506Prospective Studies030212 general & internal medicineMyocardial infarctionNon-ST Elevated Myocardial InfarctionProspective cohort studynon st-elevation acute myocardial infarction[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologyTroponin TRGlycopeptidesGeneral MedicineMiddle Aged3. Good healthchest pain onsetEmergency MedicineCardiologyMedicineFemalevery early presentersmedicine.symptomEmergency Service HospitalAdultmedicine.medical_specialtychest pain03 medical and health sciencesCopeptinPredictive Value of TestsInternal medicinePost-hoc analysisHumansAgedbusiness.industryResearchTroponin IcopeptinEmergency departmentmedicine.disease1691businessBiomarkers[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct

The lipid-lowering effects of lomitapide are unaffected by adjunctive apheresis in patients with homozygous familial hypercholesterolaemia – A post-h…

2015

AbstractObjectiveLomitapide (a microsomal triglyceride transfer protein inhibitor) is an adjunctive treatment for homozygous familial hypercholesterolaemia (HoFH), a rare genetic condition characterised by elevated low-density lipoprotein-cholesterol (LDL-C), and premature, severe, accelerated atherosclerosis. Standard of care for HoFH includes lipid-lowering drugs and lipoprotein apheresis. We conducted a post-hoc analysis using data from a Phase 3 study to assess whether concomitant apheresis affected the lipid-lowering efficacy of lomitapide.MethodsExisting lipid-lowering therapy, including apheresis, was to remain stable from Week −6 to Week 26. Lomitapide dose was escalated on the basi…

MaleTime FactorsSettore MED/09 - Medicina InternaGastroenterologyMicrosomal triglyceride transfer proteinchemistry.chemical_compoundLipoprotein apheresisMedicineHyperlipoproteinemia Type IIHomozygous familial hypercholesterolaemia; Lipoprotein apheresis; Lomitapide; Adult; Anticholesteremic Agents; Benzimidazoles; Biomarkers; Blood Component Removal; Cholesterol LDL; Combined Modality Therapy; Female; Genetic Predisposition to Disease; Humans; Hyperlipoproteinemia Type II; Lipoprotein(a); Male; Phenotype; Time Factors; Treatment Outcome; Young Adult; Homozygote; Cardiology and Cardiovascular MedicinebiologyAnticholesteremic AgentsHomozygoteLipoprotein(a)Combined Modality TherapyCholesterolPhenotypeTreatment OutcomeBlood Component Removallipids (amino acids peptides and proteins)FemaleCardiology and Cardiovascular MedicineAdultmedicine.medical_specialtySocio-culturaleLipoprotein apheresiArticleLDLHyperlipoproteinemia Type IIYoung AdultHomozygous familial hypercholesterolaemiaInternal medicinePost-hoc analysisHumansGenetic Predisposition to DiseaseHomozygous familial hypercholesterolaemia; Lipoprotein apheresis; Lomitapide; Cardiology and Cardiovascular Medicinebusiness.industryCholesterol LDLLomitapideLomitapideEndocrinologyApheresischemistryConcomitantAdjunctive treatmentbiology.proteinBenzimidazolesbusinessBiomarkersLipoprotein(a)Atherosclerosis
researchProduct